Results 161 to 170 of about 19,649 (222)

Targeting Mitochondrial Vulnerabilities in Chronic Myeloid Leukemia: From Pathobiology to Novel Therapeutic Opportunities. [PDF]

Cancers (Basel)
Caprino F, Valentino I, Bruzzese A, Ganino L, Mesuraca M, Citraro R, Gentile M, Gallo Cantafio ME, Amodio N.   +8 more
europepmc   +1 more source

Combined asciminib and olverembatinib in blast-phase chronic myeloid leukemia. [PDF]

Haematologica
Cheng F, Li W.
europepmc   +1 more source

Screening of kinase inhibitors in the triple negative KRAS G13D-mutated MDA-MB-231 breast cancer cell line. [PDF]

Sci Rep
Stickler S, Eggerstorfer MT, Rieche M, Arslan S, Teufelsbauer M, Hohenegger M, Weigl L, Hamilton G.   +7 more
europepmc   +1 more source

Hypoxic conditions confer chemoresistance to crizotinib but not to imatinib in chronic myeloid leukemia cells. [PDF]

Hematol Transfus Cell Ther
Avinery L, Regev D, Khamaisi H, Gopas J, Mahajna J.   +4 more
europepmc   +1 more source

Successful fatherhood of males with tyrosine kinase inhibitor-resistant chronic myeloid leukemia taking olverembatinib. [PDF]

Ann Hematol
Yu L, Jiang Q.
europepmc   +1 more source

Hsp70-Bim interaction mediated mitophagy as a potential therapeutic target for CML stem cells. [PDF]

Stem Cell Reports
Song T, Song Y, Zhang H, Hu Z, Yin F, Jiang M, Zhang Y, Wang Z, Zhang Z.   +8 more
europepmc   +1 more source

Pediatric chronic myeloid leukemia: A decade of clinical experience at the NBK specialized hospital for children. [PDF]

Leuk Res Rep
Bourusly M, Obaid MA, Farag N, Bourhama M, Alsharidah S, Almatar E.   +5 more
europepmc   +1 more source

Streptomyces koyangensis L-asparaginase: computational prediction of dual-mechanism BCL-2 interaction in acute lymphoblastic leukemia. [PDF]

Sci Rep
Solanki G, Prajapati C, Gadhvi R, Kamble L, Sharma MC, Hajare ST.   +5 more
europepmc   +1 more source

Computational Insights into the Polypharmacological Landscape of BCR-ABL Inhibitors: Emphasis on Imatinib and Nilotinib. [PDF]

Pharmaceuticals (Basel)
Hajjo R, Sabbah DA, Alhaded R, Alquabe'h A, Bardaweel SK.   +4 more
europepmc   +1 more source

Imatinib-induced rhabdomyolysis: A case report. [PDF]

Leuk Res Rep
Rubenstein J, Schwartz SM, Vankawala J, Caplan M, Shea S, Jurcic JG.   +5 more
europepmc   +1 more source